The primary endpoint was the time from randomization to the first major cardiovascular event, such as death due to SS pathology, non-fatal myocardial infarction, non-fatal stroke. Oval biconvex tablets from white to light yellow with the engraving “14” on one side and “novo” on the other. Oval biconvex tablets from white to light yellow with the engraving “7” on one side and “novo” on the...